Cotización Cesca Therapeutics - KOOL

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Último Precio

5.14

Postura de Compra

3.30

Postura de Venta

5.22

Volume Operado de la Acción

0.00 Rango del Día 0.00

0.00 Rango de 52 semanas 0.00

Capitalización de Mercado [m]

16.124M

Precio Anterior

5.14

Precio de Apertura

Hora

Última hora de negociación

Volumen financiero

Precio Promedio Ponderado

Volumen promedio (3 m)

Acciones en circulación

3,137,000

Rendimiento del Dividendo

Ratio Precio/Utilidad

-0.90

Beneficio por acción (BPA)

-5.73

turnover

9.45M

Beneficio neto

-17.98M

Cesca Therapeutics Inc is clinical-stage biotechnology company. The company is engaged in developing and manufacturing automated blood and bone marrow processing systems that enable the separation, processing, and preservation of cell and tissue therapy products. The company's device division, Therm... Cesca Therapeutics Inc is clinical-stage biotechnology company. The company is engaged in developing and manufacturing automated blood and bone marrow processing systems that enable the separation, processing, and preservation of cell and tissue therapy products. The company's device division, ThermoGenesis Corp, provides a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology. Cesca's clinical development division is leveraging its proprietary AutoXpress technology platform to develop autologous stem cell-based therapies that address significant unmet needs in the immuno-oncology, vascular, cardiology and orthopedic markets. Mostrar más

Sector

Lab Apparatus And Furniture

Industria

Lab Apparatus And Furniture

Sitio web

www.thermogenesis.com

Sede

Wilmington, Delaware, USA

Fundado

Cesca Therapeutics To Change Name And Ticker Symbol To Reflect New Strategic Focus

Cesca Therapeutics To Change Name And Ticker Symbol To Reflect New Strategic Focus ThermoGenesis to Focus on Developing Automated Cell Processing Tools and Services for the Cell and Gene Therapy...

Cesca Therapeutics to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference

Cesca Therapeutics to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference PR Newswire RANCHO CORDOVA, Calif., Oct. 24, 2019 RANCHO CORDOVA, Calif., Oct. 24, 2019...

Cesca Therapeutics Forms Joint Venture with Healthbanks Biotech (USA) to Provide Immune Cell Banking and Cell Processing Serv...

Cesca Therapeutics Forms Joint Venture with Healthbanks Biotech (USA) to Provide Immune Cell Banking and Cell Processing Services ImmuneCyte to Begin Operations in Fourth Quarter of 2019 PR...

Cesca Therapeutics To Announce Financial Results For The Second Quarter Ended June 30, 2019 And Host A Conference Call On Aug...

Cesca Therapeutics To Announce Financial Results For The Second Quarter Ended June 30, 2019 And Host A Conference Call On August 13 PR Newswire RANCHO CORDOVA, Calif., Aug. 6, 2019 RANCHO...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
CNEYCN Energy Group Inc	US$ 1.01 (220.03%)	50.1M
ERNAEterna Therapeutics Inc	US$ 0.65 (80.56%)	6.27M
HRTXHeron Therapeautics Inc	US$ 1.905 (61.44%)	13.07M
HTOOFusion Fuel Green PLC	US$ 0.4871 (53.18%)	9.06M
SVMHSRIVARU Holding Ltd	US$ 0.0291 (32.27%)	194.34M
ORISOriental Rise Holdings Ltd	US$ 7.22 (-39.58%)	41.72k
CTNTCheetah Net Supply Chain Service Inc	US$ 3.89 (-20.45%)	197.26k
LRFCLogan Ridge Finance Corporation	US$ 20.01 (-19.35%)	5
MOFGMidWestOne Financial Group	US$ 26.50 (-19.21%)	171
LUNRIntuitive Machines Inc	US$ 11.68 (-17.46%)	1.2M
SVMHSRIVARU Holding Ltd	US$ 0.0291 (32.27%)	194.34M
AGRIAgriFORCE Growing Systems Ltd	US$ 0.0289 (0.00%)	54.54M
CNEYCN Energy Group Inc	US$ 1.01 (220.03%)	50.1M
TANHTantech Holdings Ltd	US$ 0.1741 (6.16%)	40.64M
VIRXViracta Therapeutics Inc	US$ 0.1996 (22.60%)	31.21M